1996 Degree in Medicine and Surgery. Autonoma University of Madrid, Spain.

Size: px

Start display at page:

Download "1996 Degree in Medicine and Surgery. Autonoma University of Madrid, Spain."

Junior Anthony
6 years ago
Views:

1 CURRICULUM VITAE EDUCATION Name: Carmen Moreno, M.D. Ph.D. Phone number: Fax: Degree in Medicine and Surgery. Autonoma University of Madrid, Spain Psychiatry specialist. Education and Culture Department. Gregorio Marañón University Hospital. Madrid, Spain MA Alcala University -Psychotherapy Integrative Perspective 2002 MA Complutense University of Madrid -Forensic Psychiatry 2006 Child and Adolescent Research Fellow. Columbia University/NYSPI/Presbyterian Hospital, (NYC, USA) 2012 PhD Complutense University of Madrid PRIOR PROFESSIONAL APPOINTMENTS July December 2002: Consultant Psychiatrist in Adults Medium Term Psychiatric Impatient Unit, Complejo Asistencial Benito Menni, Ciempozuelos, Madrid. January July 2004: Consultant Psychiatrist, Child and Adolescent Out-patient Clinic, Community Mental Health Services of Villa de Vallecas, Madrid. July July 2006: Fellow in Child and Adolescent Psychiatry, Presbyterian Hospital, Columbia University,/New York State Psychiatric Institute, New York, USA. CURRENT PROFESSIONAL APPOINTMENTS Consultant in Child and Adolescent Psychiatry Department, Hospital Gregorio Marañón, Madrid, Spain, with special dedication to early-onset psychosis and affective disorders. AMITEA program, a specialty clinic devoted at the assessment and treatment of medical aspects of Autism Spectrum Disorders. Associate Professor in Psychiatry. Universidad Complutense, Facultad de Medicina, Madrid (Spain). RESEARCH PROJECTS Dr Moreno has participated in more than 20 competitively funded research projects, including internationally funded projects, being Principal investigator in 6 of them. These research projects have been funded by the 7th European Framework, Spanish Ministry of Health, Spanish Ministry of Science and Innovation, Fundación Alicia Koplowitz, CIBERSAM, Caja Navarra, Fundació La Marató, and Department of Health in the State of Madrid. She is now an investigator of the Spanish Center for Biomedical Research in Mental Health (CIBER). The CIBER is composed of 26 clinical and basic research groups belonging to 8 Autonomous Communities, which primarily research mental disorders such as depression, schizophrenia, bipolar disorder, or autism as well as any neuroscientific aspect related to health and mental illness. The approach to studying these diseases has a clear translational component. 1

2 Neuroimaging platform for characterization of metabolic co-morbidities in psychotic disorders Ruiz. Funding organization: FP7-Health-2013-INNOVATION-1 I EPSS system number: SEP Duration: Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in dementia, SZ, and MD (PRISM), Innovative Medicines Initiative 2 Joint Undertaking H2020-JTI-IMi Duración: Understanding obesity (Ob), metabolic syndrome (MetS), type 2 diabetes (T2DM) and fatty liver disease (FL): a multidisciplinary approach (PIE14/00031) Principal investigador: Celso Arango (coordinator G01) Funding organization: Proyectos excelencia interciber. Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III. Ministerio de Economía y Competitividad Duration: Etiopathological mechanisms common and differential in early onset bipolar disorder and majer depressive disorder Funding organization: Instituto de Salud Carlos III. Duration: From autism to schizophrenia: Study of the genetic mechanisms underlying brain dysfunction and structural phenotypes in schizophrenia and autistic spectrum disorders Convocatoria: ERA-NET: NEURON. European Research Project on Mental Disorders Principal Investigator: Mara Parellada (Coordinator: Marie-Odile Krebs, Université Paris Descartes) Funding organization: Instituto de Salud Carlos III. 110,000 euros Exp.: PI10/02989 Duration: European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Large Scale Integrating project. Principal Investigator (IP Celso Arango; Coordinator: Jim van Os) Funding organization: European Commission, 7th European Framework Duration: Biological mechanisms implicated in the neuroprotection with PUFAS-omega 3 in early-onset psychosis Funding organization Fundación Alicia Koplowitz 50,000 Euros Duration: Effect of a 48-week course of N-acetylcysteine (NAC) as add-on treatment on gray matter loss and oxidative metabolism, symptoms, and functioning in early-onset first-episode psychosis: a randomized, double-blind, placebocontrolled clinical trial. Principal investigator: Celso Arango Funding organization :CIBERSAM convocatoria Intramural Duration: Pediatric European Risperidone Studies. Small or Medium-Scale Focused Research Project. (PERS) Principal Investigator Celso Arango; Coordinator: JanBuitelaar. Funding organization: European Commission, 7th European Framework 2

3 Duration: Evolution of neuroanatomic alteration in early-onset bipolar disorder and etiopathological mechanisms Instituto de Salud Carlos III; F.I.S. PI10/ Duration: Analysis of the dystrobrevin-binding protein 1 gene (DTNBP1) in early onset bipolar disorder and the related neurocognitive phenotypes: an approach based in an association family study and in a complementary animal model design. Financing Entity: CIBERSAM (CIBER of Mental Health). Funding organization: from 2009 to 2011 Two years follow-up study of children and adolescents offspring of patients with schizophrenia or bipolar disorder. Principal Investigator: Dolores Moreno Funding organization Fundació La Marató de TV3. Duration: from 2009 to 2012 Psychopathologic, neuropsychologic, and neuroimaging characteristics common and differential of children and adolescents offspring of patients with schizophrenia or bipolar disorder. Principal Investigator: Dolores Moreno Funding organization: Ministry of Health, Instituto de Salud Carlos III. (PI07/0853). Duration: from 2007 to 2010 Effect of 8 weeks' treatment with omega 3 polyunsaturated fatty acids on oxidative metabolism in patients with autism spectrum disorders. Funding organization: Alicia Koplowitz Foundation. Duration: from 2007 to Effect of 8 weeks' treatment with omega 3 polyunsaturated fatty acids on oxidative metabolism in patients with autism spectrum disorders. Principal Investigator: Mara Parellada Funding organization: Ministry of Health, Instituto de Salud Carlos III (EC07/90293). Duration: from 2007 to 2010 Detection of B-7-Casomorphine in urine in patients with autism spectrum disorders Principal Investigator: Mara Parellada Funding organization: Mutua Madrileña Foundation. Duration: from 2007 to 2009 Implication of gene codifying the catechol-o-methyl transferase (COMT) in cognition and as risk factor for schizophrenia in its interaction with neurodevelopmental alterations such as neurological soft signs. Principal Investigator: Celso Arango Funding organization: Mutua Madrileña Foundation. Duration: from 2007 to 2010 Evaluación de la efectividad de un programa de atención médica integral para la población con trastornos del espectro autista Principal Investigator: Jose Romo 3

4 Funding organization: Ministerio de Sanidad y Consumo; PI09/90420 Duration: Validación de la escala Fattyacids déficit signs, FADS (Stevens LJ, et al. 1995), para muestra española. Principal Investigator: Mara Parellada Funding organization: CIBERSAM (Convocatoria del Banco de Instrumentos) Duration: (dependiente del Ensayo Clínico FIS EC07/90076) Creación de un instrumento para la evaluación de sintomatología psiquiátrica asociada a autismo susceptible de ser diana terapéutica de tratamientos farmacológicos. IP: Mara Parellada Funding organization: Bicibersam Duration: 2012 RETICS Mental Illnesses Network- Affective and Psychotic Illnesses Principal Investigator: Celso Arango Funding organization: Ministry of Health (RD06/0011/0000). SELECTED SCIENTIFIC PAPERS Moreno, C. Prevention in child and adolescent psychiatry: are we there yet? Eur Child Adolesc Psychiatry (2017) 26: 267. doi: /s Parellada M, Pina-Camacho L, Moreno C, Aleman Y, Krebs MO, Desco M, Merchán-Naranjo J, Del Rey-Mejías A, Boada L, Llorente C, Moreno D, Arango C, Janssen J. Insular pathology in young people with high-functioning autism and first-episode psychosis. Psychol Med Apr 24:1-11. doi: /S [Epub ahead of print] Sugranyes G, de la Serna E, Borras R, Sanchez-Gistau V, Pariente JC, Romero S, Baeza I, Díaz-Caneja CM, Rodriguez- Toscano E, Moreno C, Bernardo M, Moreno D, Vieta E, Castro-Fornieles J. Clinical, Cognitive, and Neuroimaging Evidence of a Neurodevelopmental Continuum in Offspring of Probands With Schizophrenia and Bipolar Disorder. Schizophr Bull Feb 9. doi: /schbul/sbx002. [Epub ahead of print] Martínez, K., Merchán-Naranjo, J., Pina-Camacho, Alemán-Gómez Y, Boada L, Fraguas D, Moreno C, Arango C, JanssenJ, Parellada M. Atypical age-dependency of executive function and white matter microstructure in children and adolescents with autism spectrum disorders. Eur Child Adolesc Psychiatry (2017). doi: /s Moron-Nozaleda G, Díaz-Caneja CM, Rodriguez-Toscano E, Arango C, Castro-Fornieles J, de la Serna E, Espliego A, Sanchez-Gistau V, Romero S, Baeza I, Sugranyes G, Moreno* C-Moreno D* (joined last authors). A developmental approach to dimensional expression of psychopathology in child and adolescent offspring of parents with bipolar disorder. Eur Child Adolesc Psychiatry (2017 (in press). Gassó P, Sánchez-Gistau V, Mas S, Sugranyes G, Rodríguez N, Boloc D, de la Serna E, Romero S, MorenoD, MorenoC, Díaz-Caneja CM, Lafuente A, Castro-Fornieles J (2016). Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. Psychiatry Research 2016 Nov 30;245: doi: /j.psychres Epub 2016 Sep 2. Pina-Camacho L, Del Rey-Mejías Á, Janssen J, Bioque M, González-Pinto A, Arango C, Lobo A, Sarró S, Desco M, Sanjuan J, Lacalle-Aurioles M, Cuesta MJ, Saiz-Ruiz J, Bernardo M, Parellada M; PEPs Group Collaborators: Cabrera B, Bargalló N, Moreno C, Alemán-Gómez Y, Fernández M, González I, Fayed N, Barcones MF, Aguilar EJ, Garcia- Marti G, Bulbena A, Bergé D, Vieta E, Torrent C, Castro-Fornieles J, Baeza I, Contreras F, Albacete A, Bobes J, García- Portilla MP, Rodriguez-Jimenez R, Morales-Muñoz I, Usall J, Butjosa A, Landin-Romero R, Pomarol-Clotet E (2016). Age at first-episode modulates diagnosis-related structural brain abnormalities in psychosis. Schizophrenia Bulletin 42(2): Calvo A, Moreno M, Ruiz-Sancho A, Rapado-Castro M, Moreno C, Sánchez-Gutiérrez 4

5 T, Arango C, Mayoral M (2015). Psychoeducational Group Intervention for Adolescents With Psychosis and Their Families: A Two-Year Follow-Up. J Am Acad Child Adolesc Psychiatry Dec;54(12): doi: /j.jaac Epub 2015 Oct 13. PubMed PMID: Parellada M, Castro-Fornieles J, Gonzalez-Pinto A, Pina-Camacho L, Moreno D, Rapado-Castro M, Otero S, del Serna E, Moreno C, Baeza I, Graell M, Arango C (2015). Predictors of Functional and Clinical Outcome in Early-Onset First- Episode Psychosis. The Journal of Clinical Psychiatry. 76(11):e1441-8, Fatjó-Vilas M, Prats C, Pomarol-Clotet E, Lázaro L, Moreno C, González-Ortega I, Lera-Miguel S, Miret S, Muñoz MJ, Ibáñez I, Campanera S, Giralt-López M,Cuesta MJ, Peralta V, Ortet G, Parellada M, González-Pinto A, McKenna PJ, Fañanás L. Involvement of NRN1 gene in schizophrenia-spectrum and bipolar disorders and its impact on age at onset and cognitive functioning. World J Biol Psychiatry Mar; 17(2): :1-11. PMID: Sanchez-Gistau V, Romero S, Moreno D, de la Serna E, Baeza I, Sugranyes G, Moreno C, Sanchez-Gutierrez T, Rodriguez-Toscano E, Castro-Fornieles J (2015). Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: a controlled study. Schizophrenia Research, 168(1-2): , (F.I.: 3.923). Garcia-Amador M, Merchán-Naranjo J, Tapia C, Moreno C, Castro-Fornieles J, Baeza I, de la Serna E, Alda JA, Muñoz D, Andrés-Nestares P, Martínez-Cantarero, Arango C (2015). Neurological side-effects of antipsychotics in children and adolescents. Journal of Clinical Psychopharmacology 35(6): Rapado-Castro M, Bartholomeusz CF, Castro-Fornieles J, González-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Bargalló N, Pantelis C, Desco M, Arango C (2015). Gender effects on brain changes in early-onset psychosis. Eur Child Adolesc Psychiatry, European Child and Adolescent Psychiatry, 24(10): , (F.I.: 3.336). Persico AM, Arango C, Buitelaar JK, Correll CU, Glennon JC, Hoekstra PJ, Moreno C, Vitiello B, Vorstman J, Zuddas A. Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives. European Child and Adolescent Clinical Psychopharmacology Network. Eur Neuropsychopharmacol Oct;25(10): Arango C, Giráldez M, Merchán-Naranjo, Baeza I, Castro-Fornieles J, Alda JA, Martinez-Cantarero C, Moreno C, de Andrés P, Cuerda C, de la Serna E, Correll CU, Fraguas D, Parellada M (2014) J. Second-Generation Antipsychotics in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients. Journal of the American Academy of Child & Adolescent Psychiatry 53(11): García-Bueno B, Bioque M, MacDowell K, Santabárbara J, Martínez M, Moreno C, Sáiz P, Berrocoso E, Gasso P, Barcones F, González-Pinto AM, Parellada M, Bobes J, Mico J, Bernardo M, Leza J. (2014). Pro/anti-inflammatory dysregulation in early psychosis: results from 1 year follow-up study. The International Journal of Neuropsychopharmacology 8(2). pii: pyu037. doi: /ijnp/pyu037 de Dios C, Goikolea JM, Colom F, Moreno C, Vieta E. Bipolar disorders in the new DSM-5 and ICD-11 classifications. Revista de psiquiatria y salud mental 2014;7: Fraguas D, Merchán-Naranjo J, del Rey-Mejías A, Castro-Fornieles J, González-Pinto A, Rapado-Castro M, Pina- Camacho L, Díaz-Caneja CM, Graell M, Otero S, Baeza I, Moreno C, Martínez-Cengotitabengoa M, Rodríguez- Toscano E, Arango C, Parellada M (2014). A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis. Schizophrenia Research 158(1-3): Díaz-Caneja CM, Moreno C, Llorente C, Espliego A, Arango C, Moreno D (2014). Practitioner Review: Long-term pharmacological treatment of pediatric bipolar disorder. J Child Psychol Psychiatry. Sep;55(9): Calvo A, Moreno M, Ruiz-Sancho A, Rapado-Castro M, Moreno C, Sanchez-Gutierrez T, Arango C, Mayoral M (2014). Intervention for Adolescents With Early-Onset Psychosis and Their Families: a Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. Jun;53(6): Martínez-Cengotitabengoa M, Mico JA, Arango C, Castro-Fornieles J, Graell M, Payá B, Leza JC, Zorrilla I, Parellada M, López MP, Baeza I, Moreno C, Rapado-Castro M, González-Pinto A (2014). Basal low antioxidant capacity correlates with cognitive deficits in earlyonset psychosis. A 2-year follow-up study. Schizophrenia Research 156,

6 Fraguas D., Del Rey-Mejías A., Moreno C., Castro-Fornieles J., Graell M4, Otero S., Gonzalez-Pinto A., Moreno D., Baeza I., Martínez-Cengotitabengoa M., Arango C., Parellada M (2014). Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study. Schizophrenia Research Jan;152(1): doi: /j.schres Epub 2013 Dec 9 Moreno C, Nuevo R, Chatterji S, Verdes E, Arango C, Ayuso-Mateos JL (2013). Psychotic symptoms are associated with physical health problems independently of a mental disorder diagnosis results from the WHO World Health Survey. World Psychiatry 12(3):251-7 Parellada M, Penzol MJ, Pina L, Moreno C, Gonzaez-Vioque E, Salzman G, Arango C (2014). The Neurobiology of Autism Spectrum Disorders. European psychiatry 29, Caamaño M, Boada L, Merchán-Naranjo J, Moreno C, Llorente C, Moreno D, Arango C, Parellada M (2013). Psychopathology in Children and Adolescents with ASD Without Mental Retardation. J Autism Dev Disord. Oct;43(10): Ramos M, Boada L, Moreno C, Llorente C, Romo J, Parellada M (2013). Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome. Drug Alcohol Depend Dec 1;133(2): PMID: Noguera A, Ballesta P, Baeza I, Arango C, de la Serna E, González-Pinto A, Parellada M, Graell M, Moreno C, Otero S, Castro-Fornieles J (2013). Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode: Discontinuation and Tolerability. J Clin Psychopharmacol Aug;33(4): Fraguas D, Moreno C (2012). Eficacia y seguridad de Aripiprazol en el tratamiento de niños y adolescentes con trastornos psiquiátricos. Revista de Psiquiatria Infanto-juvenil (AEPNYA) 29(3): Díaz-Caneja CM, Espliego A, Parellada M, Arango C, Moreno C (2012). Polypharmacy with antidepressants in children and adolescents. Int J Neuropsychopharmacol Nov 29:1-20. Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, Grant BF, Blanco C (2013). The bipolar-depressive continuum in the National Epidemiologic Survey on Alcohol and Related Conditions. Bipolar Disorders 15(1):112-3 Moreno C, Hasin DS, Arango C, Oquendo MA, Vieta E, Liu S, Grant BF, Blanco C (2012). Depression in Bipolar versus Major Depression Disorder: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Bipolar Disorders 14 (3) : Parellada M, Moreno C, Mac-Dowell K, Leza JC, Giraldez M, Bailón C, Castro C, Miranda-Azpiazu P, Fraguas D, Arango C (2012). Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res. 46(3): Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, González-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Parellada M, Moreno D, Bargalló N, Desco M (2012). Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 69(1): Janssen J, Aleman Y, Reig S, Schnack HG, Parellada M, Graell M, Moreno C, Moreno D, Mateos-Perez JM, Udias JM, Arango C, Desco M (2012). Regional specificity of thalamic volume deficits in male adolescents with early-onset psychosis. The British Journal of Psychiatry 200(1):30-6 Parellada M, Moreno C, Moreno M, Espliego E, de Portugal E, Arango C (2012). Placebo effect in child and adolescent psychiatric trials. European Neuropsychopharmacology 22(11): Parellada M, Boada L, Moreno C, Llorente C, Romo J, Muela C, Arango C (2013). Specialty Care Programme for Autism Spectrum Disorders in an Urban Population: A case-management model for health care delivery in an ASD population. European Psychiatry 69(1):16-26 Merchán-Naranjo J, Tapia C, Bailón C, Moreno C, Baeza I, Calvo-Escalona R, Morer A, Martínez-Cantarero C, Nestares PA, Alda JÁ, Muñoz D, Arango C (2012). Secondary effects of antipsychotic treatment in naive or quasinaive children and adolescents: design of a follow-up protocol and baseline results. Rev Psiquiatr Salud Ment 5(4):

7 Fraguas D, Correll CU, Merchán-Naranjo J, Rapado-Castro M, Parellada M, Moreno C, Arango C (2011). Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders. Comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol 21(8): Moreno C, Merchan-Naranjo J, Alvarez M, Baeza I, Alda JA, Martinez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M, Arango C (2010). Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and non-psychotic diagnoses. Bipolar Disorders 12(2): Mayoral M., Merchán J., Rapado M., Leiva M., Moreno C., Arango C., Giraldez M., Parellada M (2010). Neurological soft signs in juvenile patients with Asperger syndrome, early-onset psychosis, and healthy controls. Early Interv PsychiatrY 4(4): Moreno-Iniguez M, Parellada M, Moreno-Pardillo D, Mayoral M, Moreno-Ruiz C, Merchan J, Giraldez M, Leiva M, Rapado M, Delgado C, Llorente C, Tapia C, Espliego A, Rodríguez F, Arango C. UADO: a centre for the study of neuro-development within the CIBERSAM. European Journal of Psychiatry 23 (suppl 2009): Reig S, Moreno C, Moreno D, Burdalo M, Janssen J, Parellada M, Zabala A, Desco M, Arango C (2009). Progression of Brain Volume Changes in Adolescent-Onset Psychosis. Schizophrenia Bulletin 35 (1): Sublette ME, Carballo JJ, Moreno C, Galfalvy HC, Brent DA, Birmaher B, Mann JJ, Oquendo MA (2009). Substance Use Disorders and Suicide Attempts in Bipolar Subtypes. Journal of Psychiatric Research 43(3): Arango C, Moreno C, Martinez S, Parellada M, Desco M, Moreno D, Fraguas D, Gogtay N, James A, Rapoport J (2008). Longitudinal Brain Changes in Early-Onset Psychosis. Schizophrenia Bulletin 34(2): Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M (2007). National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth. Archives of General Psychiatry 64(9): Moreno C, Arango C, Parellada M, Shaffer D, Bird H (2007). Antidepressants in Child and Adolescent Depression, where are the Bugs?. Acta Psychiatrica Scandinavica 115: Moreno C, Roche AM, Greenhill LL (2006). Pharmacotherapy of Child and Adolescent Depression. Child and Adolescent Psychiatric Clinics of North America 15(4): Olfson M, Blanco C, Liu L, Moreno C, Lage G (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63(6): Moreno C, Inclán J, Palao A (2004), Estudio del impacto del 11 de septiembre en la salud mental de una población clínica de la ciudad de Nueva York. REDES, la revista de la asociación de terapia familiar del Hospital Sant Pau de Barcelona 10(4): Moreno Ruiz C, Gamo Bravo B, Pérez Fernández F (2003), Síndrome de Turner y trastornos psiquiátricos. A propósito de un caso. Psiquiatría biológica 10(6): Moreno C, Hormaechea JA, Sevilla J, González de Chávez M (2000). Vigabatrina y psicosis. A propósito de un caso. Psiquiatría Biológica 7 (2): AWARDS AND GRANTS 7

8 Award of the Spanish Society of Psychiatry: Senior Investigator Award 2011 Fellowship Award of the European College of Neuropsychopharmacology, (ECNP) 2010 Award of the Spanish Society of Psychiatry: Young Investigator Award, Grant: Two-year stay at the New York Presbyterian Hospital/ Columbia University. Alicia Koplowitz Fellowship Award for the Study of Child and Adolescent Psychiatry, Founded by Fundación Alicia Koplowitz Grant: Medical Training Program Scholarship. Agencia Española de Cooperación Internacional (AECI), Hospital de San Martín, Paraná, Argentina OTHERS Co-chair of the ECNP Child and Adolescent Psychiatric Network, 2014-current. Editor, European Child and Adolescent Psychiatry, since Member of the following Academic Societies: -American Academy of Child and Adolescent Psychiatry (AACAP), since European College of Neuropsychopharmacology (ECNP) since Asociación Española de Psiquiatría del Niño y de Adolescente (AEPNYA) since Sociedad Española de Psiquiatria (SEP) since Sociedad Española de Psiquitría Biológica (SEPB), since

Autonoma University, Madrid, (Spain) University Hospital Gregorio Marañon, Madrid, (Spain) Master s Degree in Psychotherapy

Autonoma University, Madrid, (Spain) University Hospital Gregorio Marañon, Madrid, (Spain) Master s Degree in Psychotherapy Curriculum Vitae PERSONAL INFORMATION Carmen Moreno Ruiz WORK EXPERIENCE July 2002 December 2002 Psychiatric Impatient Unit, Complejo Asistencial Benito Menni, Ciempozuelos, Madrid, (Spain) Diagnosis and